← Leaderboards
Qishen Pang
Children'S Hospital Med Ctr (Cincinnati)
$9,385,594
Attributed
$9,385,594
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $727.4K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,385,594 · 4
By mechanism
R01$9,385,594 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “S Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Peter J. Snyder · University Of Pennsylvania$35,309,252
- Jeffrey Lee Carson · Univ Of Med/Dent Nj-R W Johnson Med Sch$29,495,757
- Michael L. Terrin · Clinical Trials And Surveys Corporation$26,727,584
- Leonard I Zon · Children'S Hospital Boston$26,660,149
Research focus
S AnemiaFanconi&AposPancytopeniaLeadMouse ModelLinkSignal TransductionIn VivoLeukemiaResearch DesignHematological DiseaseHematopoiesisHematopoieticMalignant NeoplasmsComplexCellsApoptosisBiochemicalHematopoietic Stem CellsResponseMolecularBiochemical GeneticsHypersensitivityGenetic
Grant awards (28)
Role of FA Proteins in Hematopoiesis$397,500
R01 · FY2020 · HL · contact PI
FA DDR Pathway in Germline Integrity$329,925
R01 · FY2020 · HD · contact PI
Role of FA Proteins in Hematopoiesis$397,500
R01 · FY2019 · HL · contact PI
FA DDR Pathway in Germline Integrity$329,925
R01 · FY2019 · HD · contact PI
Role of FA Proteins in Hematopoiesis$397,500
R01 · FY2018 · HL · contact PI
FA DDR Pathway in Germline Integrity$329,925
R01 · FY2018 · HD · contact PI
Role of FA Proteins in Hematopoiesis$397,500
R01 · FY2017 · HL · contact PI
FA DDR Pathway in Germline Integrity$329,925
R01 · FY2017 · HD · contact PI
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy$317,475
R01 · FY2015 · CA · contact PI
Role of FA proteins in hematopoiesis$369,816
R01 · FY2014 · HL · contact PI
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy$307,951
R01 · FY2014 · CA · contact PI
Role of FA proteins in hematopoiesis$359,250
R01 · FY2013 · HL · contact PI
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy$298,427
R01 · FY2013 · CA · contact PI
Role of FA proteins in hematopoiesis$377,363
R01 · FY2012 · HL · contact PI
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy$317,475
R01 · FY2012 · CA · contact PI
Role of FA proteins in hematopoiesis$381,250
R01 · FY2011 · HL · contact PI
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy$317,042
R01 · FY2011 · CA · contact PI
Role of FA proteins in hematopoiesis$380,626
R01 · FY2010 · HL · contact PI
Role of FA protein complexes in hematopoiesis$114,540
R01 · FY2009 · HL · contact PI
Role of FA protein complexes in hematopoiesis$355,567
R01 · FY2008 · HL · contact PI
Nucleophosmin in Fanconi's Anemia-evolved Leukemia$289,623
R01 · FY2008 · CA · contact PI
Role of FA protein complexes in hematopoiesis$353,197
R01 · FY2007 · HL · contact PI
Nucleophosmin in Fanconi's Anemia-evolved Leukemia$289,623
R01 · FY2007 · CA · contact PI
Role of FA protein complexes in hematopoiesis$363,746
R01 · FY2006 · HL · contact PI
Role of Nucleophosmin in FA-evolved Leukemia$298,273
R01 · FY2006 · CA · contact PI
Role of FA protein complexes in hematopoiesis$373,750
R01 · FY2005 · HL
Role of Nucleophosmin in FA-evolved Leukemia$305,450
R01 · FY2005 · CA
Nucleophosmin in Fanconi's Anemia-evolved Leukemia$305,450
R01 · FY2004 · CA